UC DAVIS SUPERFUND RESEARCH PROGRAM Superfund sites are diverse, and many include unknown chemicals, chemicals of unknown toxicity and/or toxic degradation products. Currently, methods to detect, prioritize, and remediate these chemicals are incomplete or nonexistent. The UC Davis Superfund Research Center (UCD-SRC) will conduct research to: (i) improve understanding of the mechanisms by which hazardous chemicals produce adverse health effects, (ii) develop, validate and integrate novel methods to evaluate chemical exposures, levels of contamination, and health risks, and (iii) develop innovative remediation strategies to reduce hazardous substance exposure and toxicity. To achieve these goals the SRC consists of 5 integrated projects, 2 research support cores, a training core, a community engagement core, a research translation core and an administrative core. The UCD-SRC will use integrated chromatographic, biosensor and cell based technologies to detect and identify contaminants and develop innovative approaches for bioremediation. Rapid immunochemical and cell based analysis will supplement classical technologies for the evaluation of sites, as well as determining human susceptibility, exposure and effect. Fundamental mechanisms of toxic action of selected chemicals will be explored to predict risk and develop new biomarkers. This mechanistic knowledge will be extended in vivo with an emphasis on mechanism of toxicity. We are expanding the use of transcriptomics, proteomics, metabolomics and integrated bioinformatics technologies to discover new mechanisms of action of hazardous materials and biomarkers for their action and to connect hazardous substance exposures to organism level effects. The biomarkers developed in this project will serve as biological dosimeters in exposure studies. All aspects of the program will be connected to our Community Engagement Core, and subject to community approval will be demonstrated on Yurok Tribal Lands. Technologies developed by the SRC will be tested at field sites and transferred to end users through a research translation core. Program Relevance We will develop sensitive systems for evaluating and mitigating the risk of hazardous chemicals on human populations and the environment using biomarkers of both exposure and effect.

Public Health Relevance

UC DAVIS SUPERFUND RESEARCH PROGRAM The UC Davis Superfund Research Center conducts research to: (i) improve understanding of the mechanisms by which hazardous chemicals produce adverse health effects, (b) develop, validate and integrate novel methods to evaluate chemical exposures, levels of contamination, and health risks, and (c) develops innovative remediation strategies to reduce hazardous substance exposure and toxicity. These activities will improve the ability of the National Superfund Program to address legacy and emerging contaminants and associated transformation products to more comprehensively protect the U.S. population from health risks posed by hazardous substances.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Hazardous Substances Basic Research Grants Program (NIEHS) (P42)
Project #
5P42ES004699-31
Application #
9683883
Study Section
Special Emphasis Panel (ZES1)
Program Officer
Henry, Heather F
Project Start
1997-04-01
Project End
2022-03-31
Budget Start
2019-04-01
Budget End
2020-03-31
Support Year
31
Fiscal Year
2019
Total Cost
Indirect Cost
Name
University of California Davis
Department
Zoology
Type
Earth Sciences/Resources
DUNS #
047120084
City
Davis
State
CA
Country
United States
Zip Code
95618
Taha, Ameer Y; Hennebelle, Marie; Yang, Jun et al. (2018) Regulation of rat plasma and cerebral cortex oxylipin concentrations with increasing levels of dietary linoleic acid. Prostaglandins Leukot Essent Fatty Acids 138:71-80
Hill 3rd, Thomas; Rice, Robert H (2018) DUOX expression in human keratinocytes and bronchial epithelial cells: Influence of vanadate. Toxicol In Vitro 46:257-264
Kodani, Sean D; Wan, Debin; Wagner, Karen M et al. (2018) Design and Potency of Dual Soluble Epoxide Hydrolase/Fatty Acid Amide Hydrolase Inhibitors. ACS Omega 3:14076-14086
Ren, Qian; Ma, Min; Yang, Jun et al. (2018) Soluble epoxide hydrolase plays a key role in the pathogenesis of Parkinson's disease. Proc Natl Acad Sci U S A 115:E5815-E5823
Pecic, Stevan; Zeki, Amir A; Xu, Xiaoming et al. (2018) Novel piperidine-derived amide sEH inhibitors as mediators of lipid metabolism with improved stability. Prostaglandins Other Lipid Mediat 136:90-95
Yamanashi, Haruto; Boeglin, William E; Morisseau, Christophe et al. (2018) Catalytic activities of mammalian epoxide hydrolases with cis and trans fatty acid epoxides relevant to skin barrier function. J Lipid Res 59:684-695
Wang, Fuli; Zhang, Hongyong; Ma, Ai-Hong et al. (2018) COX-2/sEH Dual Inhibitor PTUPB Potentiates the Antitumor Efficacy of Cisplatin. Mol Cancer Ther 17:474-483
Napimoga, M H; Rocha, E P; Trindade-da-Silva, C A et al. (2018) Soluble epoxide hydrolase inhibitor promotes immunomodulation to inhibit bone resorption. J Periodontal Res 53:743-749
Blöcher, René; Wagner, Karen M; Gopireddy, Raghavender R et al. (2018) Orally Available Soluble Epoxide Hydrolase/Phosphodiesterase 4 Dual Inhibitor Treats Inflammatory Pain. J Med Chem 61:3541-3550
Hao, Lei; Kearns, Jamie; Scott, Sheyenne et al. (2018) Indomethacin Enhances Brown Fat Activity. J Pharmacol Exp Ther 365:467-475

Showing the most recent 10 out of 1149 publications